Company News
Vanda Shares Rise 7.9% on NEREUS Launch
Vanda Pharmaceuticals announced commercial availability of NEREUS™ (tradipitant) for adult motion‑sickness prevention across the United States.
The drug, first new prescription for motion sickness in
